Bayer will discontinue phase II development candidate eliapixant
Review of development program led to reassessment of benefit-risk ratio in all four potential indications for ...
Read more
Tag: bayer
Bayer appoints Christine Roth as new Head of Oncology Strategic Business Unit at Pharmaceuticals Division
Bayer today announced Christine Roth as the new Head of the Oncology Strategic Business Unit at ...
Read more
Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer
Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. and ...
Read more
Atal Innovation Mission collaborates with Bayer to work towards healthcare innovations
Atal Innovation Mission (AIM), NITI Aayog today collaborated with Bayer- a global enterprise with core competencies ...
Read moreInvestigational Combination of Aliqopa® (copanlisib) and rituximab helps in non-Hodgkin’s Lymphoma
In the Phase III trial CHRONOS-3 of 458 patients with indolent non-Hodgkin’s Lymphoma (iNHL), the investigational ...
Read moreBayer receives approval for Vitrakvi™ in Japan
Bayer announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing ...
Read more